MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
0.877
+0.004 (0.40%)
At close: Apr 28, 2026, 4:00 PM EDT
0.860
-0.018 (-2.00%)
After-hours: Apr 28, 2026, 6:41 PM EDT
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $93.73 million as of April 28, 2026. Its market cap has decreased by -65.83% in one year.
Market Cap
93.73M
Enterprise Value
8.29M
1-Year Change
-65.83%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since the IPO on March 10, 2021, MaxCyte's market cap has decreased from $494.67M to $93.73M, a decrease of -81.05%. That is a compound annual growth rate of -27.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 93.43M | -43.49% |
| Dec 31, 2025 | 165.34M | -62.39% |
| Dec 31, 2024 | 439.69M | -9.93% |
| Dec 29, 2023 | 488.14M | -12.55% |
| Dec 30, 2022 | 558.17M | -45.87% |
| Dec 31, 2021 | 1.03B | 108.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Treace Medical Concepts | 127.95M |
| Hyperfine | 127.09M |
| Nano-X Imaging | 120.74M |
| Neuronetics | 116.89M |
| Rapid Micro Biosystems | 104.35M |
| Outset Medical | 82.77M |
| Sera Prognostics | 78.68M |
| QT Imaging Holdings | 77.85M |